SCHEMBL23578399

SCHEMBL23578399

CCOC(=O)[C@H](Cc1ccc(N)cc1)NN1C(=O)c2ccccc2C1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 1/20 0.48
▸ PPID Q08752 3/20 0.44
▸ HPRT1 P00492 1/20 0.43
▸ PDCD1 Q15116 1/20 0.42
▸ CD274 Q9NZQ7 1/20 0.42
▸ ELANE P08246 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ MMP8 P22894 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ STAT3 P40763 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23578402 1.00 BACE1 (0.48) BACE1PPIDHPRT1PDCD1CD274
SCHEMBL29235935 0.84 BACE1 (0.48) BACE1TP53MEN1MAPTKMT2A
SCHEMBL30034403 0.84 BACE1 (0.48) BACE1TP53MEN1MAPTKMT2A
SCHEMBL9631343 0.79 HSD11B1 (0.60) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL8787113 0.78 ALDH1A1 (0.49) ALDH1A1MEN1MAPTKMT2APKM
Hydrochloric Acid SCHEMBL9630160 0.78 HSD11B1 (0.59) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL3935801 0.74 CTSL (0.60) PPIDTP53ALDH1A1LMNA
SCHEMBL7607209 0.74 CTSL (0.60) PPIDTP53ALDH1A1LMNA
Hydrochloric Acid SCHEMBL5967158 0.74 ALDH1A1 (0.46) ELANEALDH1A1MEN1MAPTKMT2A
Hydrochloric Acid SCHEMBL5967154 0.74 ALDH1A1 (0.46) ELANEALDH1A1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081503-B1 A PROCESS FOR THE SYNTHESIS OF MELPHALAN INDENA SPA (IT) 2025-07-30 — — EP disclosed
US-12077484-B2 Process for the synthesis of melphalan INDENA S.P.A. (IT) 2024-09-03 — — US disclosed
CN-114845991-B Method for synthesizing melphalan 意迪那有限公司 2024-05-07 — — CN disclosed
US-11787761-B2 Process for the synthesis of Melphalan INDENA S.P.A. (IT) 2023-10-17 — — US disclosed
US-20230286901-A1 PROCESS FOR THE SYNTHESIS OF MELPHALAN INDENA S.P.A. (IT) 2023-09-14 — — US disclosed
US-20230094970-A1 A PROCESS FOR THE SYNTHESIS OF MELPHALAN INDENA S.P.A. (IT) 2023-03-30 — — US disclosed
EP-4081503-A1 A PROCESS FOR THE SYNTHESIS OF MELPHALAN Indena S.p.A. (IT) 2022-11-02 — — EP disclosed
CN-114845991-A Method for synthesizing melphalan 因德纳有限公司 2022-08-02 — — CN disclosed
WO-2021130163-A1 A PROCESS FOR THE SYNTHESIS OF MELPHALAN INDENA S.P.A. (IT) 2021-07-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230094970-A1 A PROCESS FOR THE SYNTHESIS OF MELPHALAN PAH, IL4I1, TYR BACE1 4654/4885PPID 2507/4885HPRT1 605/4885
US-12077484-B2 Process for the synthesis of melphalan PAH, TYR, IL4I1 BACE1 4646/4885PPID 2185/4885HPRT1 646/4885
US-11787761-B2 Process for the synthesis of Melphalan PAH, TYR, MARS1 BACE1 4594/4885PPID 2060/4885HPRT1 654/4885
US-20230286901-A1 PROCESS FOR THE SYNTHESIS OF MELPHALAN PAH, TYR, IL4I1 BACE1 4646/4885PPID 2185/4885HPRT1 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback